L-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain

被引:82
作者
Bezard, E
Gross, CE
Qin, L
Gurevich, VV
Benovic, JL
Gurevich, EV
机构
[1] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA
[2] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[3] China Agr Univ, Lab Anim Res Ctr, Beijing, Peoples R China
[4] Univ Bordeaux 2, CNRS UMR 5543, F-33076 Bordeaux, France
关键词
arrestin; G protein-coupled receptor kinase; dyskinesia; Parkinson disease;
D O I
10.1016/j.nbd.2004.10.005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Dysregulation of dopamine receptors (DARs) is believed to contribute to Parkinson disease (PD) pathology. G protein-coupled receptors (GPCR) undergo desensitization via activation-dependent phosphorylation by G protein-coupled receptor kinases (GRKs) followed by arrestin binding. Using quantitative Western blotting, we detected profound differences in the expression of arrestin2 and GRKs among four experimental groups of nonhuman primates: (1) normal, (2) parkinsonian, (3) parkinsonian treated with levodopa without or (4) with dyskinesia. Arrestin2 and GRK6 expression was significantly elevated in the MPTP-lesioned group in most brain regions; GRK2 was increased in caudal caudate and internal globus pallidus. Neither levodopa-treated group differed significantly from control. The only dyskinesia-specific change was an elevation of GRK3 in the ventral striatum of the dyskinetic group. Changes in arrestin and GRK expression in the MPTP group were accompanied by enhanced ERK activation and elevated total ERK expression, which were also reversed by L-DOPA. The data suggest the involvement of arrestins and GRKs in Parkinson disease pathology and the effects of levodopa treatment. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:323 / 335
页数:13
相关论文
共 74 条
[1]   ESTIMATION OF NUCLEAR POPULATION FROM MICROTOME SECTIONS [J].
ABERCROMBIE, M .
ANATOMICAL RECORD, 1946, 94 (02) :239-247
[2]   Desensitization, internalization, and signaling functions of β-arrestins demonstrated by RNA interference [J].
Ahn, S ;
Nelson, CD ;
Garrison, TR ;
Miller, WE ;
Lefkowitz, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) :1740-1744
[3]  
ARRIZA JL, 1992, J NEUROSCI, V12, P4045
[4]   Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder [J].
Barrett, TB ;
Hauger, RL ;
Kennedy, JL ;
Sadovnick, AD ;
Remick, RA ;
Keck, PE ;
McElroy, SL ;
Alexander, M ;
Shaw, SH ;
Kelsoe, JR .
MOLECULAR PSYCHIATRY, 2003, 8 (05) :546-557
[5]  
BENOVIC JL, 1993, J BIOL CHEM, V268, P19521
[6]   A complex program of striatal gene expression induced by dopaminergic stimulation [J].
Berke, JD ;
Paletzki, RF ;
Aronson, GJ ;
Hyman, SE ;
Gerfen, CR .
JOURNAL OF NEUROSCIENCE, 1998, 18 (14) :5301-5310
[7]   Presymptomatic compensation in Parkinson's disease is not dopamine-mediated [J].
Bezard, E ;
Gross, CE ;
Brotchie, JM .
TRENDS IN NEUROSCIENCES, 2003, 26 (04) :215-221
[8]   Compensatory mechanisms in experimental and human parkinsonism: Towards a dynamic approach [J].
Bezard, E ;
Gross, CE .
PROGRESS IN NEUROBIOLOGY, 1998, 55 (02) :93-116
[9]   Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease [J].
Bezard, E ;
Dovero, S ;
Prunier, C ;
Ravenscroft, P ;
Chalon, S ;
Guilloteau, D ;
Crossman, AR ;
Bioulac, B ;
Brotchie, JM ;
Gross, CE .
JOURNAL OF NEUROSCIENCE, 2001, 21 (17) :6853-6861
[10]   Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies [J].
Bezard, E ;
Brotchie, JM ;
Gross, CE .
NATURE REVIEWS NEUROSCIENCE, 2001, 2 (08) :577-588